{{Infobox drug
| drug_name =
| type =
| IUPAC_name = 4-<nowiki/>{1-Hydroxy-2-[(1-methyl-2-phenoxyethyl)amino]propyl}phenol
| image = Isoxsuprine.svg
| width = 250 
| alt =
| caption =

<!-- Clinical data -->
| pronounce ={{IPAc-en|aɪ|ˈ|s|ɒ|k|sj|uː|p|r|iː|n}}  {{respell|eye|SOCK|sew-preen}}
| tradename = Duvadilan, Vasodilan
| Drugs.com =
| MedlinePlus = a682831
| pregnancy_AU = <!-- A/B1/B2/B3/C/D/X -->
| pregnancy_AU_comment = 
| pregnancy_US = C
| pregnancy_category = 
| routes_of_administration = Oral ([[Tablet (pharmacy)|tablets]])
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_AU_comment =
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_DE = <!-- Anlage I, II, III -->
| legal_NZ = <!-- Class A, B, C -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM / Class A, B, C -->
| legal_US = <!-- OTC/Rx-only/Schedule I, II, III, IV, V -->
| legal_UN = <!-- N I, II, III, IV / P I, II, III, IV-->
| legal_status = ℞-only

<!-- Pharmacokinetic data -->
| bioavailability = ~100% (humans),<ref>{{cite book|last1=McGuigan|first1=Michael A.|last2=Whyte|first2=Ian MacGregor|last3=Dawson|first3=Andrew H.|last4=Seifert|first4=Steven A.|last5=Schonwald|first5=Seth|last6=Yip|first6=Luke|last7=Keyes|first7=Daniel C.|last8=Hurlbut|first8=Katherine M.|last9=Erdman|first9=Andrew R.|last10=Dart|first10=Richard C.|editor1-last=Dart|editor1-first=Richard C.|title=Medical Toxicology|date=2004|publisher=Lippincott Williams & Wilkins|location=Philadelphia [u.a.]|isbn=0781728452|page=718|edition=3rd|chapter=125. Vasodilators}}</ref> 2.2% (horses; oral)<ref>{{cite journal|last1=Erkert|first1=RS|last2=Macallister|first2=CG|title=Isoxsuprine hydrochloride in the horse: a review|journal=Journal of veterinary pharmacology and therapeutics|date=April 2002|volume=25|issue=2|pages=81–7|pmid=12000527|doi=10.1046/j.1365-2885.2002.00386.x}}</ref>
| protein_bound = 
| metabolism = 
| metabolites =
| onset = 1 hour
| elimination_half-life = <3 hours (horses)<ref>{{cite book|editor1-last=Cole|editor1-first=Cynthia|editor2-last=Bentz|editor2-first=Bradford|editor3-last=Maxwell|editor3-first=Lara|title=Equine pharmacology|date=2014|publisher=Wiley—Blackwell|isbn=978-0-8138-2262-4|page=224|chapter=13. Clinical pharmacology of the equine musculoskeletal system}}</ref>
| duration_of_action =
| excretion = Mainly [[Kidney|renal]]

<!-- Identifiers -->
| CAS_number = 395-28-8
| ATCvet = 
| ATC_prefix = C04
| ATC_suffix = AA01
| PubChem = 3783
| DrugBank = DB08941
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1197051
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08092
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = R15UI3245N
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3651
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C18H23NO3/c1-13(12-22-17-6-4-3-5-7-17)19-14(2)18(21)15-8-10-16(20)11-9-15/h3-11,13-14,18-21H,12H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = BMUKKTUHUDJSNZ-UHFFFAOYSA-N
| SMILES = O(c1ccccc1)CC(NC(C)C(O)c2ccc(O)cc2)C

<!-- Chemical data -->
| chemical_formula = | C=18 | H=23 | N=1 | O=3
| molecular_weight = 
}}

'''Isoxsuprine''' (used as '''isoxsuprine hydrochloride''') is a drug used as a [[vasodilator]]<ref name="pmid6488912">{{cite journal |author=Gozo EG, Yebes RB |title=Hemodynamic effects of isoxsuprine in cardiac failure |journal=Chest |volume=86 |issue=5 |pages=736–40 |date=November 1984 |pmid=6488912 |doi= 10.1378/chest.86.5.736|url=http://www.chestjournal.org/cgi/pmidlookup?view=long&pmid=6488912}}</ref> in [[human]]s (under the trade name '''Duvadilan''') and [[equine]]s. Isoxsuprine is a [[Beta2-adrenergic agonist|β<sub>2</sub> adrenoreceptor agonist]] that causes direct relaxation of uterine and vascular smooth muscle via [[Beta-2 adrenergic receptor|β<sub>2</sub> receptor]]s.<ref>{{Cite journal | last1 = Falkay | first1 = G. | last2 = Kovács | first2 = L. | title = Affinity of tocolytic agents on human placental and myometrial beta-adrenergic receptors | journal = Journal of perinatal medicine | volume = 14 | issue = 2 | pages = 109–113 | year = 1986 | pmid = 2874205 | doi=10.1515/jpme.1986.14.2.109}}</ref>

==Use ==

===In humans===
Isoxsuprine it is used in humans for treatment of premature labor, i.e. a [[tocolytic]],<ref>{{Cite journal | last1 = Giorgino | first1 = F. L. | last2 = Egan | first2 = C. G. | title = Use of isoxsuprine hydrochloride as a tocolytic agent in the treatment of preterm labour: A systematic review of previous literature | journal = Arzneimittel-Forschung | volume = 60 | issue = 7 | pages = 415–20 | year = 2010 | pmid = 20712130 | doi=10.1055/s-0031-1296305}}</ref> and as a vasodilator for the treatment of cerebral vascular insufficiency, [[Raynaud's phenomenon]], and other conditions.<ref>Drugs.com: [http://www.drugs.com/mtm/isoxsuprine.html Isoxsuprine]</ref>

Isoxsuprine may increase the heart rate, cause changes in blood pressure, and irritate the GI tract. It should therefore be used with caution if combined with other drugs that affect blood pressure, such as [[sedative]]s and [[anesthetic]] drugs.  

===In horses===
Isoxsuprine is most commonly used to treat hoof-related problems in the horse, most commonly for [[laminitis]] and [[navicular disease]], as its effects as a vasodilator are thought to increase circulation within the hoof to help counteract the problems associated with these conditions.  Isoxsuprine is given orally, and many horses find the pills quite palatable.<ref>{{cite book | author = Forney, Barbara C | title = Equine Medications | publisher = Blood Horse Publications | location = Lexington, KY | year = 2007}}</ref>  Isoxsuprine is a prohibited class B drug in [[International Federation for Equestrian Sports|FEI]]-regulated competition, and is often prohibited by other equine associations. It may be detected in the urine for several weeks or months following administration. It is therefore important to check the drug-rules within an animal's given competitive organization, before administering the drug.  

Because it is a vasodilator, it should not be used in horses that are bleeding, or in mares following foaling.

==References==
{{reflist|2}}

{{Peripheral vasodilators}}
{{Adrenergic receptor modulators}}
{{Ionotropic glutamate receptor modulators}}

[[Category:Alcohols]]
[[Category:Amines]]
[[Category:Beta-adrenergic agonists]]
[[Category:Equine medications]]
[[Category:NMDA receptor antagonists]]
[[Category:Phenol ethers]]
[[Category:Phenols]]
[[Category:Vasodilators]]